BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 29976150)

  • 21. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
    Choi JU; Chung SW; Al-Hilal TA; Alam F; Park J; Mahmud F; Jeong JH; Kim SY; Byun Y
    Biomaterials; 2017 Sep; 139():56-66. PubMed ID: 28586719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma.
    Shinriki S; Jono H; Ueda M; Ota K; Ota T; Sueyoshi T; Oike Y; Ibusuki M; Hiraki A; Nakayama H; Shinohara M; Ando Y
    J Pathol; 2011 Sep; 225(1):142-50. PubMed ID: 21710490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma.
    Franchi A; Massi D; Santucci M; Masini E; Rossi Degl'Innocenti D; Magnelli L; Fanti E; Naldini A; Ardinghi C; Carraro F; Gallo O
    J Pathol; 2006 Feb; 208(3):439-45. PubMed ID: 16278821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
    Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
    J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
    Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
    Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
    Miyahara M; Tanuma J; Sugihara K; Semba I
    Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The expression of vascular endothelial growth factor-C in oral squamous cell carcinoma and its associations with angiogenesis, lymphangiogenesis and lymph node metastasis].
    Chen SX; Li XY; Kong XL; Feng Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Jun; 28(3):319-23. PubMed ID: 20635667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma.
    Ishii H; Chikamatsu K; Sakakura K; Miyata M; Furuya N; Masuyama K
    Oral Oncol; 2010 May; 46(5):373-8. PubMed ID: 20308006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
    Hwang-Bo J; Yoo KH; Park JH; Jeong HS; Chung IS
    Int J Cancer; 2012 Jul; 131(2):298-309. PubMed ID: 21823121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathways targeting tumor lymphangiogenesis.
    Wissmann C; Detmar M
    Clin Cancer Res; 2006 Dec; 12(23):6865-8. PubMed ID: 17145802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
    Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y; Opeskin K; Goad J; Williams ED
    Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.
    Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H; Guo Y
    Cancer Res; 2010 Mar; 70(6):2495-503. PubMed ID: 20197464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head and neck squamous cell carcinoma lymphatic spread and survival: Relevance of vascular endothelial growth factor family for tumor evaluation.
    de Sousa EA; Lourenço SV; de Moraes FP; Vartanian JG; Gonçalves-Filho J; Kowalski LP; Soares FA; Coutinho-Camillo CM
    Head Neck; 2015 Oct; 37(10):1410-6. PubMed ID: 24824527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
    Lien MY; Tsai HC; Chang AC; Tsai MH; Hua CH; Wang SW; Tang CH
    Front Immunol; 2018; 9():412. PubMed ID: 29599774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
    Tobler NE; Detmar M
    J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis.
    Matsumoto M; Roufail S; Inder R; Caesar C; Karnezis T; Shayan R; Farnsworth RH; Sato T; Achen MG; Mann GB; Stacker SA
    Clin Exp Metastasis; 2013 Aug; 30(6):819-32. PubMed ID: 23591595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of vascular endothelial growth factors A and C in oral squamous cell carcinoma.
    Yanase M; Kato K; Yoshizawa K; Noguchi N; Kitahara H; Nakamura H
    J Oral Pathol Med; 2014 Aug; 43(7):514-20. PubMed ID: 24762199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.
    Ma C; Luo C; Yin H; Zhang Y; Xiong W; Zhang T; Gao T; Wang X; Che D; Fang Z; Li L; Xie J; Huang M; Zhu L; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
    Gastric Cancer; 2018 Jul; 21(4):617-631. PubMed ID: 29243194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.